The role of OB/GYNs in delivering personalized breast care
Endroit courant :
> This Story

Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment




Ultrasound Homepage

New study calls for prebiopsy MR scans in prostate cancer assessment Better able to detect cancers that likely require treatment

Dense breast laws not boosting ultrasound screening rates: study Researchers suggest risk of overdiagnosis may outweigh benefits in some cases

Ultrasound tomography system provides greater insight than conventional ultrasound Produces optical acoustic and laser ultrasound images

FUJIFILM SonoSite, Partners HealthCare to enhance point-of-care ultrasound with AI partnership Open access to affordable point-of-care ultrasound

Neurologica agrees to discounts for Strategic Radiology members Discounts on digital radiography and ultrasound, software and services

Global breast ultrasound market expected to reach $1.7 billion by 2023 Driven by novel vendor techniques, machine learning and deep-learning algorithms

OB/GYN ultrasound: is the field ready to adopt new technology in the market? What do new capabilities mean for creatures of habit?

Hologic puts forth $85 million offer to buy SuperSonic Imagine An entry into cart-based breast ultrasound market

MR and ultrasound biopsies combined can detect prostate cancers, says study Detect up to 33 percent more tumors together

Fujifilm SonoSite brings new workflow solution to point of care ultrasound Addressing top priorities to reduce administrative burden on providers

The role of OB/GYNs in delivering personalized breast care

From the July 2019 issue of DOTmed HealthCare Business News magazine

By: Dr. Serena Tidwell

As obstetrician-gynecologists (OB/GYN), we play a significant role in the overall health of our patients.
The well-woman examination — an annual health check-up for breast and gynecological diseases — often leads to a broader discussion of a patient’s overall health. For many patients, this may be their only general healthcare exam, so we need to make it count.

There’s no doubt among the medical community that breast health is an important part of wellness. Yet, we often see a lot of confusion around breast screening recommendations from various healthcare authoritative bodies. At what age should we start screening? How often? When to stop? As OB/GYNs, we are frequently looked to as experts to guide our patients, even though there is little focus on breast care in medical school. At my clinic, we’ve taken this responsibility seriously and have created clear guidelines with the objective to personalize breast care for our patients.
Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs

I opened Pink Monarch Breast Center in 2012 as a subsidiary of our OB/GYN practice to increase our patient screening rates. I saw too many patients who were not going for annual mammograms. Fortunately, this significantly changed when I was able to conveniently schedule the mammogram at the same time and location as their physical exam.

Early detection of breast cancer is critical. In fact, finding it early reduces a woman’s risk of dying from the disease by 25-30 percent or more. If the cancer is only located in the breast, the five-year survival rate is 99 percent. Even for cancers found at stages one and two, chemotherapy can be avoided in 70% of cases.

We also offer a personalized and multi-modality screening approach because we know that no two women are the same. There are a variety of genetic and lifestyle factors that create a woman’s individual risk of breast cancer.

In recent years, there has been an increased focus on the risks associated with having dense breast tissue. Specifically, there is the risk of masking on a mammogram (both cancer and dense tissue appear white, making cancer hard to spot). In addition, dense breast tissue composition may encourage cancer to grow. Approximately 40% of American women have dense breast tissue, which means almost half of the patients we see daily are women with dense breast tissue. This single risk factor increases the likelihood of these patients being diagnosed with breast cancer.

While mammography remains the gold standard to detect breast cancer, there are supplemental technologies that can improve cancer detection in dense breasts. At Pink Monarch Breast Center, we offer automated breast ultrasound (ABUS), which can help see through dense tissue. I have seen first-hand the benefits that supplemental screening can offer our dense breast patients. Most notably, our cancer detection rates have increased by finding small cancers missed by 2D and 3D mammography.
  Pages: 1 - 2 >>

Ultrasound Homepage

You Must Be Logged In To Post A Comment